Roumen Radinov, Ph.D.Vice President, Process Sciences at Alnylam PharmaceuticalsSpeaker
Profile
Roumen Radinov received his Ph.D. in organic chemistry from Sofia University, Bulgaria. Following postdoctoral studies in enantioselective methodology and asymmetric synthesis at the University of Geneva, Duke and Stanford, he joined the Roche Chemical Synthesis Department in 1997 where he has developed and scaled up the syntheses of multiple drug candidates including oligonucleotide drug substance and excipients for the Roche siRNA program. In 2012 he joined Alnylam Pharmaceuticals where he is currently leading drug product development and process development of custom starting materials, excipients, and novel technologies for oligonucleotide manufacture.
Agenda Sessions
Adoption of Innovative Technologies in Oligonucleotide Manufacturing: Improving Efficiency of siRNA Manufacturing Processes
, 2:00pmView Session